Therapeutic response to rituximab in neuromyelitis optica in a Mexican population

被引：0
|
作者：
Hernandez, L. [1 ]
Skromne, E. [1 ]
机构：
[1] Ctr Med Nacl Siglo XXI, Mexico City, DF, Mexico
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P186
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [1] Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica Influence of FCGR3A Polymorphisms on the Therapeutic Response to Rituximab
    Kim, Su-Hyun
    Jeong, In Hye
    Hyun, Jae-Won
    Joung, Aeran
    Jo, Hyo-Jin
    Hwang, Sang-Hyun
    Yun, Sooin
    Joo, Jungnam
    Kim, Ho Jin
    [J]. JAMA NEUROLOGY, 2015, 72 (09) : 989 - 995
  • [2] Treatment outcomes with rituximab in 100 patients with neuromyelitis optica: influence of FCGR3A polymorphism on the therapeutic response to rituximab
    Kim, S. -H.
    Jeong, I. H.
    Hyun, J-W.
    Joung, A.
    Cho, H. -J.
    Hwang, S. -H.
    Yun, S.
    Joo, J.
    Kim, H. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 49 - 49
  • [3] Therapeutic response to rituximab in seropositive neuromyelitis optica: Experience from a tertiary care center in South India
    James, Joe
    Jose, James
    Smita, B.
    Balaram, Neetha
    [J]. JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2023, 14 (02) : 327 - 332
  • [4] Efficacy of rituximab in refractory neuromyelitis optica
    Collongues, N.
    Brassat, D.
    Maillart, E.
    Labauge, P.
    Ouallet, J. C.
    Carra-Dalliere, C.
    Moreau, T.
    Bourre, B.
    Papeix, C.
    Brochet, B.
    Audoin, B.
    Vukusic, S.
    de Seze, J.
    Marignier, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (07) : 955 - 959
  • [5] Efficacy of rituximab in refractory neuromyelitis optica
    Collongues, N.
    Brassat, D.
    Maillart, E.
    Labauge, P.
    Ouallet, J. -C.
    Carra-Dalliere, C.
    Moreau, T.
    Bourre, B.
    Papeix, C.
    Audoin, B.
    Brochet, B.
    Vukusic, S.
    De Seze, J.
    Marignier, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 78 - 79
  • [6] Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder
    Umeton, Raffaella Pizzolato
    Waltz, Michael
    Aaen, Gregory S.
    Benson, Leslie
    Gorman, Mark
    Goyal, Manu
    Graves, Jennifer S.
    Harris, Yolanda
    Krupp, Lauren
    Lotze, Timothy E.
    Shukla, Nikita M.
    Mar, Soe
    Ness, Jayne
    Rensel, Mary
    Schreiner, Teri
    Tillema, Jan-Mendelt
    Roalstad, Shelly
    Rodriguez, Moses
    Rose, John
    Waubant, Emmanuelle
    Weinstock-Guttman, Bianca
    Casper, Charles
    Chitnis, Tanuja
    [J]. NEUROLOGY, 2023, 100 (09) : E985 - E994
  • [7] Efficacy of rituximab in refractory neuromyelitis optica
    Collongues, N.
    Brassat, D.
    Maillart, E.
    Labauge, P.
    Ouallet, J. -C.
    Dalliere, C. Carra
    Moreau, T.
    Bourre, B.
    Papeix, A. -C.
    Audouin, B.
    Brochet, B.
    Vukusic, S.
    De Seze, J.
    Marignier, R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 86 - 86
  • [8] Optimizing rituximab therapy for neuromyelitis optica
    Dean M. Wingerchuk
    Brian G. Weinshenker
    [J]. Nature Reviews Neurology, 2011, 7 : 664 - 665
  • [9] Rituximab in neuromyelitis optica: A review of literature
    Ericka Wong
    Vijay A Vishwanath
    Ilya Kister
    [J]. World Journal of Neurology, 2015, (01) : 39 - 46
  • [10] MECHANISM OF RITUXIMAB IN THE TREATMENT OF NEUROMYELITIS OPTICA
    Yuan, Chunhua
    Liu, Ying
    Hao, Yankun
    Yan, Lei
    Liang, Jun
    Jin, Huipeng
    [J]. FARMACIA, 2022, 70 (04) : 636 - 642
12345